New diabetes clinical trial: The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

Published on: June 16, 2024 at 11:00PM
Conditions: Type 2 Diabetes; Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
Interventions: Drug: Glucagon-like peptide-1 receptor agonist：Semaglutide
Sponsors: The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting
https://ift.tt/p0ENiXr